Besifloxacin
Overview
Besifloxacin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201760).
API suppliers (1)
Suppliers of Besifloxacin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
- RUYUAN HEC PHARM CO LTD
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Besifloxacin expires 9 Jan 2031. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
- Canonical SMILES
- C1CCN(C[C@@H](C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F
- InChIKey
- QFFGVLORLPOAEC-SNVBAGLBSA-N
Do you supply Besifloxacin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.